<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Merck.com - Product News</title>
<link>http://www.merck.com/newsroom/news-release-archive/product/</link>
<description>Merck.com - Product News</description>
<image>
	<title>Merck.com - Product News</title>
	<width>142</width>
	<height>42</height>
	<link>http://www.merck.com/newsroom/news-release-archive/product/</link>
	<url>http://www.merck.com/site_images/mercklogo-rss.jpg</url>
</image>
<item>
	<title>U.S. District Court Rules Against Merck in TEMODAR&amp;reg; (temozolomide) Patent Lawsuit</title>
	<guid isPermaLink="false">USDistrictCourtR01/26/2010</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/product/?src=rss</link>
	<pubDate>Tue, 26 Jan 2010 00:00:00 GMT</pubDate>
</item>
<item>
	<title>FDA Approves ZEGERID OTC&amp;trade; for Over-the-Counter Treatment of Frequent Heartburn</title>
	<guid isPermaLink="false">FDAApprovesZEGER12/01/2009</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/product/2009_1201a.html?src=rss</link>
	<pubDate>Tue, 01 Dec 2009 00:00:00 GMT</pubDate>
</item>
<item>
	<title>U.S. Department of Health &amp; Human Services Recommends Merck's First-in-Class Integrase Inhibitor ISENTRESS&amp;reg; (raltegravir) Tablets, in Combination Therapy, as a Preferred Regimen for Treatment-Naïve Patients with HIV-1 Infection</title>
	<guid isPermaLink="false">USDepartmentofHe12/01/2009</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/product/2009_1201.html?src=rss</link>
	<pubDate>Tues, 01 Dec 2009 00:00:00 GMT</pubDate>
</item>
</channel>
</rss>